ZyVersa Therapeutics Inc (ZVSA)

Inflammation Study Links Alzheimer’s Disease With Chronic Heart Disease


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
April 30, 2024
Report ID: 26677
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


ZyVersa Therapeutics Inc
ZyVersa Therapeutics Inc
Financial Services
Diversified Financial Services
Ticker
ZVSA
Current Price
$3.78 -5.97%
Market Cap
$3.2M
Price Target
Refer to Report
Volume
80.0K
52wk Range
$3.94 - $115.15
Related Research Reports
4/30/2024

Inflammation Study Links Alzheimer’s Disease With Chronic Heart Disease
Inflammation Study Links Alzheimer’s Disease With Chronic Heart Disease (ZVSA)
3/26/2024

FY23 Reported With Reiteration of Milestones For Kidney and Inflammasome Trials
FY23 Reported With Reiteration of Milestones For Kidney and Inflammasome Trials (ZVSA)
1/18/2024

Research Study Details Role Of Inflammasomes In TNBC Brain Metastases
Research Study Details Role Of Inflammasomes In TNBC Brain Metastases (ZVSA)
1/3/2024

Novel Therapies For Renal Diseases and Inflammation
Novel Therapies For Renal Diseases and Inflammation (ZVSA)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy